Glymidine (sodium)
Glymidine sodium is an oral active antidiabetic. Glymidine sodium is the inhibitor of hepatic lipolysis. Glymidine sodium inhibits the glucose formation and supresses the elevated pyruvate oxidation which results from the inhibition of endogenous lipid mobilization[1].
Product Specifications
CAS Number
[3459-20-9]
Product Name Alternative
Gondafon; Glycodiazine
UNSPSC
12352005
Target
Insulin Receptor
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/glymidine-sodium.html
Purity
98.48
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=S([N-]C1=NC=C(OCCOC)C=N1)(C2=CC=CC=C2)=O.[Na+]
Molecular Formula
C13H14N3NaO4S
Molecular Weight
331.32
References & Citations
[1]Menahan LA, et al. The role of endogenous lipid in gluconeogenesis and ketogenesis of perfused rat liver. Eur J Biochem. 1969;9 (2) :182-188.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
APEX1 (DNA- (Apurinic or Apyrimidinic Site) Lyase, APEX Nuclease, APEN, Apurinic-apyrimidinic Endonuclease 1, AP Endonuclease 1, APE-1, REF-1, Redox Factor-1, APE, APE1, APEX, APX, HAP1, REF1) (MaxLight 550)
